Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 4, 2012, Pages 373-384

  Billman, George E ^a   Gögelein, Heinz ^b   Ruetten, Hartmut ^b   Wirth, Klaus J ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Amiodarone; Antiarrhythmic; Myocardial ischemia; Ventricular fibrillation

Indexed keywords

AMIODARONE; DOFETILIDE; FLECAINIDE; FLECAINIDE ACETATE; PENTOBARBITAL; SAR 114646A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE PREDISPOSITION; DOG; DRUG EFFICACY; DRUG INHIBITION; ELECTROSTIMULATION; EXERCISE; EXTRASYSTOLE; FEMALE; HEART ATRIUM; HEART INFARCTION; HEART PACING; HEART VENTRICLE FIBRILLATION; IN VIVO STUDY; MALE; NONHUMAN; PROGRAMMED ELECTRICAL STIMULATION; SWINE; THORACOTOMY; VENTRICULAR TACHYPACING;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DISEASE MODELS, ANIMAL; DOGS; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; MALE; SWINE; VENTRICULAR FIBRILLATION;

EID: 84862841633     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0716-9     Document Type: Article

References (53)

1. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile, and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230-246 (Pubitemid 34327903)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an im-plantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237 (Pubitemid 40110811)
3. Belardinelli L, Shryock JC, Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92(Suppl 4): iv6-iv14 (Pubitemid 43974036)
4. Billman GE (1989) The effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation. J Pharmacol Exp Ther 248:1334-1342 (Pubitemid 19100792)
5. Billman GE (1991) The antiarrhythmic and antifibrillatory effects of calcium antagonists. J Cardiovasc Pharmacol 18(Suppl 10):S107-S117
6. Billman GE (2006) A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Phar-macol Ther 111:808-835 (Pubitemid 44160523)
7. Billman GE (2008) The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Pharmacol Ther 120:54-70
8. Billman GE (2009) Cardiac autonomic neural "remodeling" and sus-ceptibility to sudden cardiac death: effect of endurance exercise training. Am J Physiol Heart Circ Physiol 297:H1171-H1193
9. Billman GE, Hamlin RL (1996) The effects ofanovel calcium channel antagonist, mibefradil, on refractory period and arrhythmias in-duced by programmed electrical stimulation and myocardial is-chemia: a comparison with diltiazem and verapamil. J Pharmacol Exp Ther 277:1517-1526 (Pubitemid 27167167)
10. Billman GE, Hoskins RS (1989) Time series analysis of heart rate variability during submaximal exercise: evidence for reduced cardiac vagal tone in animals susceptible to ventricular fibrillation. Circulation 80:146-157 (Pubitemid 19178648)
11. Billman GE, Schwartz PJ, Stone HL (1982) Baroreceptor reflex control ofheart rate: a predictor of sudden death. Circulation 66:874-880 (Pubitemid 12015075)
12. Billman GE, Avendano CE, Halliwill JR, Burroughs JM (1993) The effects of the ATP-dependent potassium channel antagonist gly-buride on coronary blood flow and susceptibility to ventricular fibrillation. J Cardiovasc Pharmacol 21:197-204 (Pubitemid 23027594)
13. Billman GE, Englert HC, Schoelkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel; part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286:1465-1473 (Pubitemid 29135563)
14. Billman GE, Houle MS, Englert HC, Goegelein H (2004) The effects of a novel cardioselective ATP-sensitive potassium channel an-tagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-ß-methoxye-thaoxyphenyl]sulfonyl] -3-methylhiourea, sodium salt, (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: In vitro and in vivo studies. J Pharmacol Exp Ther 309:182-192 (Pubitemid 38393129)
15. Blaauw Y, Gogelein H, Tieleman RG, van HA, Schotten U, Allessie MA (2004) "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remod-eled atria of the goat Circulation 110:1717-1724 (Pubitemid 39299211)
16. Blaauw Y, Schotten U, van HA, Neuberger HR, Allessie MA (2007) Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat Cardi-ovasc Res 75:89-98 (Pubitemid 46873519)
17. 2+ and HCN channels. Naunyn Schmiedebergs Arch Pharmacol 383:347-356
18. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, Giunti G, Mugelli A (1997) Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation 95:568-571 (Pubitemid 27063029)
19. Cerbai E, Sartiani L, DePaoli P, Pino R, Maccherini M, Bizzarri F, DiCiolla F, Davoli G, Sani G, Mugelli A (2001) The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 33:441-448 (Pubitemid 32539001)
20. Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA (1998) Intrave-nous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 81:594-598
21. DiFrancesco D (2006) Funny channels in the control ofcardiac rhythm and mode of action of selective blockers. Pharmacol Res 53:399-406
22. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U (2005) The G protein-gated potassium current I(K, ACh) is constitutively active in patients with chronic atrial fibril-lation. Circulation 112:3697-3706 (Pubitemid 43739509)
23. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A (2002) Amiodarone as compared with lidocaine for shock-resistant ven-tricular fibrillation. N Engl J Med 346:884-890 (Pubitemid 34984636)
24. Friederich P (2003) Basic concepts of ion channel physiology and anaesthetic drug effects. Eur J Anaesthesiol 20:343-353 (Pubitemid 36597037)
25. Goegelein H, Gautier P, Roccon A, O'Connor S, Ruetten H (2011) Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 384:231-244
26. Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR, Murphy E (2007) A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 4:1250-1255
27. Halliwill JR, Billman GE (1992) The effect of general anesthesia on cardiac vagal tone. Am J Physiol Heart Circ Physiol 262:H1719-H1724
28. Hamlin RL, Altschuld RA (2011) Extrapolation from mouse to man. Circ Cardiovasc Imaging 4:2-4
29. Hohnloser SH (2009) New pharmacological options for patients with atrial fibrillation: the ATHENA trial. Rev Esp Cardiol 62:479-481
30. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ (1998) Hyperpolarization- activated inward current in ventricular myo-cytes from normal and failing human hearts. Circulation 97:55-65 (Pubitemid 28036155)
31. Janse MJ, Wit AL (1989) Electrophysiological mechanisms ofventric-ular arrhythmias resulting from myocardial ischemia and infarc-tion. Physiol Rev 69:1049-1169 (Pubitemid 19255835)
32. Kerr CR, Rosenbaum MB, Chiale PA (1996) Amiodarone. In: Messerli FN (ed) Cardiovascular drug therapy. Saunders, Philadelphia, pp 1247-1264
33. Koncz I, Szél T, Jaeger K, Baczkó I, Cerbai E, Romanelli MN, Papp JG, Varró A (2011) Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible thera-peutical targets. Curr Med Chem 668:3662-3674
34. Kowey PR Levine JH, Herre JM, Pacifico A, Lindsay BD, Plumb VJ, Janosik DL, Kopelman HA, Scheinman MM (1995) Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment ofpatients with recurrent, hemodynamically destabiliz-ing ventricular tachycardia or fibrillation. The Intravenous Amiodar-one Multicenter Investigators Group. Circulation 92:3255-3263
35. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341:871-878 (Pubitemid 29427049)
36. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction oftotal cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lan-cet 351:478-484 (Pubitemid 28070094)
37. Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes A, Woosley RL (1996) Intravenous amiodar-one for recurrent sustained hypotensive ventricular tachyarrhyth-mias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 27:67-75 (Pubitemid 26018919)
38. Lukas A, Antzelevitch C (1993) Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation 88:2903-2915 (Pubitemid 23360218)
39. Maltsev VA, Sabbah HN, Undrovinas AL (2001) Late sodium current is a novel target for amiodarone: studies in faling human myocar-dium. J Mol Cell Cardiol 33:923-932 (Pubitemid 32545327)
40. Michels G, Er F, Khan I, Sudkamp M, Herzig S, Hoppe UC (2005) Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation 111:399-404 (Pubitemid 40204422)
41. Platou ES, Refsum H (1986) Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. Acta Pharmacol Toxicol (Copenh) 58:163-168 (Pubitemid 16080506)
42. Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR (1995) Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multi-center Investigators Group. Circulation 92:3264-3272
43. Schwartz PJ (1998) Do animal models have clinical value? Am J Cardiol 81:14D-20D (Pubitemid 28155906)
44. Schwartz PJ, Billman GE, Stone HL (1984) Autonomic mechanisms in ventricular fibrillation due to acute myocardial ischemia during exercise in dogs with healed myocardial infarction: an experimen-tal model for sudden cardiac death. Circulation 69:790-800 (Pubitemid 14125661)
45. Schwartz PJ, Vanoli E, Stramba-Badiale M, DeFerrari GM, Billman GE, Foreman RD (1988) Autonomic mechanisms and sudden death, new insight from the analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circu-lation 78:969-979
46. Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, Nattel S (2008) Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 45:289-299
47. Van de Water A, Verheyen J, Xhonnex R, Reneman RS (1989) An improved method to correct QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22:207-217 (Pubitemid 19275446)
48. Vanoli E, Hull SS Jr, Adamson PB, Smith SL, Foreman RD, Schwartz PJ (1998) Dronedarone, a new amiodarone-like compound, pre-vents ventricular fibrillation in conscious dogs with healed myo-cardial infarctions. Circulation 98(Abstract Suppl I):I-817
49. Vassallo P, Trohman RG (2007) Prescribing amiodarone: an evidence-based review ofclinical indications. JAMA 298:1312-1322 (Pubitemid 47449439)
50. Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M (2003) Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. Cardiovasc Res 60:298-306 (Pubitemid 37412363)
51. Wirth KJ, Brendel J, Steinmeyer K, Linz DK, Rutten H, Gogelein H (2007) In vitro and in vivo effects of the atrial selective antiar-rhythmic compound AVE1231. J Cardiovasc Pharmacol 49:197-206 (Pubitemid 46626011)
52. Wu L, Rajamani S, Shryock JC, Li H, Ruskin J, Antzelevitch C, Belardinelli L (2008) Augmentation of the late sodium current unmasks the proarrhythmic effects of amiodarone. Cardiovasc Res 77:481-488 (Pubitemid 351197663)
53. Zimetbaum P (2007) Amiodarone for atrial fibrillation. N Engl J Med 356:935-941